Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Ruibao Biotechnology is a leading Chinese enterprise specializing in the research, development, and industrial-scale production of natural plant extracts and pigments. Founded in 1998, the company has established itself as a major global supplier of marigold-derived lutein and zeaxanthin, which are critical components in eye health supplements and nutraceuticals. Beyond eye health, Ruibao produces capsanthin and other natural colorants for the food, pharmaceutical, and cosmetic sectors. The company manages a vertically integrated supply chain, from specialized seed breeding and marigold cultivation to high-tech extraction and purification processes. Headquartered in Kunming, Yunnan, Ruibao is a high-tech enterprise listed on the National Equities Exchange and Quotations (NEEQ: 835421). Their manufacturing facilities adhere to international standards, including GMP, ISO, and Kosher certifications, ensuring high-quality ingredients for the global market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Ruibao Biotechnology.